Screening for Abdominal Aortic Aneurysm Using a Portable Transthoracic Echocardiography Among Patients With Acute Coronary Syndrome

NCT01863524 | Completed

• 1 other identifier: emc130152ctil
• Study Type: observational
• Target: 90
• Locations: 1 country
• Sites: 2

Brief Summary

The prevalence of Abdominal Aortic Aneurysm among 65 years old individuals worldwide is 1-2%. when diagnosis is confirmed by abdominal Ultrasound the prevalence is 5.5% in men and 1% in women. As abdominal aortic aneurysm and coronary heart disease share common risk factors, patients with acute coronary syndrome represent a high risk population in which screening for another atherosclerotic site is recommended. Patients admitted for ACS undergo routinely TTE. during the same study, TTE may offer the opportunity to evaluate the cardiac morphology and function and to screen for Abdominal Aortic aneurysm. It was reported by different studies that the Sensitivity of this technique was between 91-96% for AAA screening. In addition, this method is cheap, available and requires only 2-3 minutes to be added to the standard TTE. we plan to examine patients admitted with ACS in our Intensive Care Unit for screening AAA by TTE in subcostal views in addition to the standard TTE examination.

Conditions

Acute Coronary Syndrome

Keywords

Abdominal Aortic Aneurysm (AAA),; Echocardiography (TTE),; Acute Coronary Syndrome (ACS); Patients over 65 years old

Outcome Measures

Primary Outcomes (1)

• Abdominal aortic diameter measurement of 30 mm or more by portable transthoracic echocardiography, will be defined as abdominal aortic aneurysm.

  Average time period of 72 hours.

Eligibility Criteria

• Age: 65 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients over 65 years old with ACS admitted in Intensive Cardiac Care Unit, who will be examined by TTE.

You may qualify if:

• patients over 65 years old with ACS. patients capable of reading, understanding and signing informed concent

You may not qualify if:

• suboptimal TTE windows

Sponsors & Collaborators

• HaEmek Medical Center, Israel: lead

Study Sites (2)

HaEmek MC Cardiology depratment

Afula, 18100, Israel

Location

Haemek Medical Center

Afula, Israel

Location

MeSH Terms

Conditions

Acute Coronary Syndrome; Aortic Aneurysm, Abdominal

Condition Hierarchy (Ancestors)

Myocardial Ischemia; Heart Diseases; Cardiovascular Diseases; Vascular Diseases; Aortic Aneurysm; Aneurysm; Aortic Diseases

Study Officials

• Mohamad Jabaren, MD

  Haemek Medical Center, Afula, Israel

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: MD

Study Record Dates

• First Submitted: May 14, 2013
• First Posted: May 29, 2013
• Study Start: May 1, 2013
• Primary Completion: July 1, 2015
• Study Completion: July 1, 2015
• Last Updated: December 6, 2016

Record last verified: 2016-12

Data Sharing

• IPD Sharing: Will not share

Locations

IL (2)